+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Endovenous Ablation Devices Market 2019-2023 - Product Image

Global Endovenous Ablation Devices Market 2019-2023

  • ID: 4801827
  • Report
  • Region: Global
  • 124 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AngioDynamics Inc.
  • Medtronic Plc
  • Sciton Inc.
  • Teleflex Inc.
  • Venclose Inc.
  • MORE
Global Endovenous Ablation Devices Market: About this market

Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These devices are designed to perform minimally invasive procedures. This endovenous ablation devices market analysis considers sales from the endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices segments. Our analysis also considers the sales of endovenous ablation devices in Asia, Europe, North America, and ROW. In 2018, the EVLT segment held the highest market share. This trend is expected to remain prevalent over the forecast period. Factors such as the high success rate of EVLT devices compared with others and their ability to perform minimally invasive procedures without spinal or general anesthesia are helping the EVLT segment in maintaining its leading market position. Also, our global endovenous ablation devices report has observed market growth factors such as the increasing prevalence of CVI, growing demand for MI endovenous ablation procedures, and technological advances in endovascular ablation devices. However, challenges such as high cost coupled with unfavorable reimbursement policies, limitations and complications associated with endovenous ablation techniques, and shortage of skilled vascular surgeons may hamper the growth of the endovenous ablation devices industry over the forecast period.

Global Endovenous Ablation Devices Market: Overview

Increasing prevalence of CVI

One of the high risk factors for CVI is aging. Therefore, the growing geriatric population will increase the incidence of CVI. Other risk factors include obesity, smoking, and pregnancy, which are also prevalent. Moreover, CVI is a progressive medical condition, which worsens with time. As a result, the need for effective treatment of CVI is increasing. Therefore, the sales of endovenous ablation devices have been increasing, which will lead to the expansion of the global endovenous ablation devices market. The market will grow at a CAGR of almost 4% during the forecast period.

Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA

The EVSA method has better patient tolerance compared with EVLA and RFA. This factor is attributed to the minute and flexible catheter of EVSA compared with the stiff glass fibers of EVLA and RFA. EVSA catheters can easily be inserted into veins without inflicting pain on the patient. Therefore, the emergence of EVSA as an alternative to EVLA and RFA will have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global endovenous ablation devices market is concentrated. This robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading endovenous ablation devices manufacturers, which include AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., and Venclose Inc.

Also, the endovenous ablation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AngioDynamics Inc.
  • Medtronic Plc
  • Sciton Inc.
  • Teleflex Inc.
  • Venclose Inc.
  • MORE

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TECHNOLOGY

  • Market segmentation by technology
  • Comparison by technology
  • EVLT devices - Market size and forecast 2018-2023
  • RFA devices - Market size and forecast 2018-2023
  • NTNT devices - Market size and forecast 2018-2023
  • Market opportunity by technology

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing popularity of performing endovenous procedures in an outpatient setting
  • Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA
  • Strategic partnerships, M&A, and marketing initiatives by vendors

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AngioDynamics Inc.
  • Medtronic Plc
  • Sciton Inc.
  • Teleflex Inc.
  • Venclose Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits:
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Technology - Market share 2018-2023 (%)
Exhibit 18: Comparison by technology
Exhibit 19: EVLT devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: EVLT devices - Year-over-year growth 2019-2023 (%)
Exhibit 21: RFA devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: RFA devices - Year-over-year growth 2019-2023 (%)
Exhibit 23: NTNT devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: NTNT devices - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by technology
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: AngioDynamics Inc. - Vendor overview
Exhibit 46: AngioDynamics Inc. - Business segments
Exhibit 47: AngioDynamics Inc. - Organizational developments
Exhibit 48: AngioDynamics Inc. - Geographic focus
Exhibit 49: AngioDynamics Inc. - Segment focus
Exhibit 50: AngioDynamics Inc. - Key offerings
Exhibit 51: AngioDynamics Inc. - Key customers
Exhibit 52: Medtronic Plc - Vendor overview
Exhibit 53: Medtronic Plc - Business segments
Exhibit 54: Medtronic Plc - Organizational developments
Exhibit 55: Medtronic Plc - Geographic focus
Exhibit 56: Medtronic Plc - Segment focus
Exhibit 57: Medtronic Plc - Key offerings
Exhibit 58: Medtronic Plc - Key customers
Exhibit 59: Sciton Inc. - Vendor overview
Exhibit 60: Sciton Inc. - Product segments
Exhibit 61: Sciton Inc. - Organizational developments
Exhibit 62: Sciton Inc. - Key offerings
Exhibit 63: Sciton Inc. - Key customers
Exhibit 64: Teleflex Inc. - Vendor overview
Exhibit 65: Teleflex Inc. - Business segments
Exhibit 66: Teleflex Inc. - Organizational developments
Exhibit 67: Teleflex Inc. - Geographic focus
Exhibit 68: Teleflex Inc. - Segment focus
Exhibit 69: Teleflex Inc. - Key offerings
Exhibit 70: Teleflex Inc. - Key customers
Exhibit 71: Venclose Inc. - Vendor overview
Exhibit 72: Venclose Inc. - Product segments
Exhibit 73: Venclose Inc. - Organizational developments
Exhibit 74: Venclose Inc. - Key offerings
Exhibit 75: Venclose Inc. - Key customers
Exhibit 76: Validation techniques employed for market sizing
Exhibit 77: Definition of market positioning of vendors

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AngioDynamics Inc.
  • Medtronic Plc
  • Sciton Inc.
  • Teleflex Inc.
  • Venclose Inc.
  • MORE
The following companies are recognised as the key players in the global endovenous ablation devices market: AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., and Venclose Inc.

Commenting on the report, an analyst from the research team said: “Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA.”

According to the report, one of the major drivers for this market is the increasing prevalence of CVI.

Further, the report states that one of the major factors hindering the growth of this market is the high cost coupled with unfavorable reimbursement policies.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AngioDynamics Inc.
  • Medtronic Plc
  • Sciton Inc.
  • Teleflex Inc.
  • Venclose Inc.
Note: Product cover images may vary from those shown
Adroll
adroll